Prescriptions for category D and X drugs during pregnancy in Taiwan: A population-based study

Li Ting Kao, Yi Hua Chen, Herng Ching Lin, Shiu Dong Chung

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Purpose: This study aimed to investigate the most prescribed medications and principle diagnoses for category D and X drugs during pregnancy using a population-based dataset in Taiwan. Methods: The data for the present study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We selected 14125 women who had live singleton births between 1 January 2009 and 31 December 2011. In total, 217226 prescriptions prescribed to these pregnant women were identified. Results: Of the total 217226 prescriptions, 1.1% were category D or X drugs; in the first, second, and third trimesters of pregnancy, 1.8%, 0.7%, and 0.5% of prescriptions were category D or X drugs, respectively. Progestins (15.3%) and propylthiouracil (10.7%) were the two most frequently prescribed category D or X drugs during pregnancy. In particular, progestins (20.4%) and estrogens (15.6%) were the most frequently prescribed category D or X drug in the first trimester of pregnancy. Propylthiouracil was the most prescribed category D or X drug in the second (20.3%) and third trimesters (23.1%) of pregnancy, respectively. The most common principal diagnosis during pregnancy was "disorders of menstruation and other abnormal bleeding from the female genital tract" (22% of all principal diagnoses for prescribing category D and X drugs). Conclusions: Our study found that the physicians obviously reduced the use of category D and X drugs for women after becoming aware that they were pregnant. Copyright
原文英語
頁(從 - 到)1029-1034
頁數6
期刊Pharmacoepidemiology and Drug Safety
23
發行號10
DOIs
出版狀態已發佈 - 十月 1 2014

指紋

Taiwan
Prescriptions
Pregnancy
Pharmaceutical Preparations
Population
Propylthiouracil
Third Pregnancy Trimester
Second Pregnancy Trimester
Progestins
First Pregnancy Trimester
Menstruation Disturbances
Live Birth
Health Insurance
Pregnant Women
Estrogens
Databases
Hemorrhage
Physicians

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Epidemiology
  • Medicine(all)

引用此文

Prescriptions for category D and X drugs during pregnancy in Taiwan : A population-based study. / Kao, Li Ting; Chen, Yi Hua; Lin, Herng Ching; Chung, Shiu Dong.

於: Pharmacoepidemiology and Drug Safety, 卷 23, 編號 10, 01.10.2014, p. 1029-1034.

研究成果: 雜誌貢獻文章

@article{28d3525b5a534b499c2f341a4e032eaa,
title = "Prescriptions for category D and X drugs during pregnancy in Taiwan: A population-based study",
abstract = "Purpose: This study aimed to investigate the most prescribed medications and principle diagnoses for category D and X drugs during pregnancy using a population-based dataset in Taiwan. Methods: The data for the present study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We selected 14125 women who had live singleton births between 1 January 2009 and 31 December 2011. In total, 217226 prescriptions prescribed to these pregnant women were identified. Results: Of the total 217226 prescriptions, 1.1{\%} were category D or X drugs; in the first, second, and third trimesters of pregnancy, 1.8{\%}, 0.7{\%}, and 0.5{\%} of prescriptions were category D or X drugs, respectively. Progestins (15.3{\%}) and propylthiouracil (10.7{\%}) were the two most frequently prescribed category D or X drugs during pregnancy. In particular, progestins (20.4{\%}) and estrogens (15.6{\%}) were the most frequently prescribed category D or X drug in the first trimester of pregnancy. Propylthiouracil was the most prescribed category D or X drug in the second (20.3{\%}) and third trimesters (23.1{\%}) of pregnancy, respectively. The most common principal diagnosis during pregnancy was {"}disorders of menstruation and other abnormal bleeding from the female genital tract{"} (22{\%} of all principal diagnoses for prescribing category D and X drugs). Conclusions: Our study found that the physicians obviously reduced the use of category D and X drugs for women after becoming aware that they were pregnant. Copyright",
keywords = "Category D and X drugs, Pharmacoepidemiology, Pregnancy, Prescribing behavior",
author = "Kao, {Li Ting} and Chen, {Yi Hua} and Lin, {Herng Ching} and Chung, {Shiu Dong}",
year = "2014",
month = "10",
day = "1",
doi = "10.1002/pds.3599",
language = "English",
volume = "23",
pages = "1029--1034",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Prescriptions for category D and X drugs during pregnancy in Taiwan

T2 - A population-based study

AU - Kao, Li Ting

AU - Chen, Yi Hua

AU - Lin, Herng Ching

AU - Chung, Shiu Dong

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Purpose: This study aimed to investigate the most prescribed medications and principle diagnoses for category D and X drugs during pregnancy using a population-based dataset in Taiwan. Methods: The data for the present study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We selected 14125 women who had live singleton births between 1 January 2009 and 31 December 2011. In total, 217226 prescriptions prescribed to these pregnant women were identified. Results: Of the total 217226 prescriptions, 1.1% were category D or X drugs; in the first, second, and third trimesters of pregnancy, 1.8%, 0.7%, and 0.5% of prescriptions were category D or X drugs, respectively. Progestins (15.3%) and propylthiouracil (10.7%) were the two most frequently prescribed category D or X drugs during pregnancy. In particular, progestins (20.4%) and estrogens (15.6%) were the most frequently prescribed category D or X drug in the first trimester of pregnancy. Propylthiouracil was the most prescribed category D or X drug in the second (20.3%) and third trimesters (23.1%) of pregnancy, respectively. The most common principal diagnosis during pregnancy was "disorders of menstruation and other abnormal bleeding from the female genital tract" (22% of all principal diagnoses for prescribing category D and X drugs). Conclusions: Our study found that the physicians obviously reduced the use of category D and X drugs for women after becoming aware that they were pregnant. Copyright

AB - Purpose: This study aimed to investigate the most prescribed medications and principle diagnoses for category D and X drugs during pregnancy using a population-based dataset in Taiwan. Methods: The data for the present study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We selected 14125 women who had live singleton births between 1 January 2009 and 31 December 2011. In total, 217226 prescriptions prescribed to these pregnant women were identified. Results: Of the total 217226 prescriptions, 1.1% were category D or X drugs; in the first, second, and third trimesters of pregnancy, 1.8%, 0.7%, and 0.5% of prescriptions were category D or X drugs, respectively. Progestins (15.3%) and propylthiouracil (10.7%) were the two most frequently prescribed category D or X drugs during pregnancy. In particular, progestins (20.4%) and estrogens (15.6%) were the most frequently prescribed category D or X drug in the first trimester of pregnancy. Propylthiouracil was the most prescribed category D or X drug in the second (20.3%) and third trimesters (23.1%) of pregnancy, respectively. The most common principal diagnosis during pregnancy was "disorders of menstruation and other abnormal bleeding from the female genital tract" (22% of all principal diagnoses for prescribing category D and X drugs). Conclusions: Our study found that the physicians obviously reduced the use of category D and X drugs for women after becoming aware that they were pregnant. Copyright

KW - Category D and X drugs

KW - Pharmacoepidemiology

KW - Pregnancy

KW - Prescribing behavior

UR - http://www.scopus.com/inward/record.url?scp=84911806944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911806944&partnerID=8YFLogxK

U2 - 10.1002/pds.3599

DO - 10.1002/pds.3599

M3 - Article

C2 - 24578346

AN - SCOPUS:84911806944

VL - 23

SP - 1029

EP - 1034

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 10

ER -